Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated.
Saved in:
| Title: | Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated. |
|---|---|
| Authors: | Andereggen L; Department of Neurosurgery, Neurocenter and Regenerative Neuroscience Cluster Inselspital, Bern University Hospital, Bern, Switzerland. lukas.andereggen@gmail.com.; Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland. lukas.andereggen@gmail.com., Frey J; Department of Gynecology and Obstetrics, Kantonsspital Lucerne, Lucerne, Switzerland., Christ E; Department of Endocrinology, Diabetology and Metabolism, University Hospital of Basel, Basel, Switzerland. |
| Source: | Endocrine [Endocrine] 2021 Apr; Vol. 72 (1), pp. 216-222. Date of Electronic Publication: 2020 Dec 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9434444 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0100 (Electronic) Linking ISSN: 1355008X NLM ISO Abbreviation: Endocrine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1559-0100 |
|---|---|
| DOI: | 10.1007/s12020-020-02557-1 |
